| ||||||||||||||
|
|
|||||||||||||

*Associate Professor of Anesthesiology/Surgery, Department of Anesthesiology, The University of Utah College of Medicine, Salt Lake City, Utah 84132.
Instructor in Anesthesiology, Department of Anesthesiology, The University of Utah College of Medicine, Salt Lake City, Utah 84132.
Abstract
The cardiovascular effects of 2 and 3 mg/kg of meperidine plus 60 to 67% N2O in O2 on cardiovascular dynamics in man were measured before and after the administration of 0.08 mg/kg of IV pancuronium. N2O and 2 mg/kg of meperidine did not change heart rate (HR) but produced a marked reduction (–49%) in cardiac output (
T) plus significant decreases in stroke volume (SV) and blood pressure (BP) and an increase in peripheral arterial resistance (PVR). Additional meperidine did not further alter any of the variables; however, surgical stimulation caused significant increases in HR, BP, and PVR. SV and
T were not significantly changed by surgical stimulation and were still markedly depressed when compared to control values. Pancuronium produced marked increases in HR, SV,
T, and BP and a reduction in PVR. These changes were maximal 4 to 8 minutes after pancuronium and returned toward pre-pancuronium values thereafter. These data demonstrate that N2O-meperidine anesthesia results in a moderate reduction in BP but a marked depression in
T. The findings also indicate that pancuronium reverses the cardiovascular depression produced by N2O-meperi-dine and is therefore, a desirable muscle relaxant when the above technic is employed.
|